Tag

Medication Safety

Tabula Rasa HealthCare® Named Principal Distributor of the BioIntelliSense BioSticker™ for Programs of All-Inclusive Care for the Elderly (PACE)

Moorestown, NJ – March 17, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters into an agreement with BioIntelliSense to distribute its BioSticker™, the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring. The BioIntelliSense DaaS platform can be applied to a wide range of clinical use cases, including monitoring for the key symptoms associated with COVID-19 . “BioSticker remote monitoring... Read More

Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results

MOORESTOWN, NJ, February 27, 2020 — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the fourth quarter and full year ended December 31, 2019. Full Year 2019 Highlights • Total revenue increased 39% to $284.7 million; • Non-GAAP Adjusted EBITDA increased 29% to $37.9 million; • Non-GAAP Adjusted diluted EPS increased to $0.79 from $0.77; • Product revenue increased 22% to... Read More

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

Moorestown, NJ, January 13, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All-inclusive Care for the Elderly) market to begin 2020. PACE organizations nationwide rely on TRHC’s PACE division, CareVention HealthCare,™ for technology, services, and consulting to optimize outcomes and maintain regulatory compliance. CareVention’s lead offering for PACE providers is medication... Read More